4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-009718
Chief Financial Officer sold 399 shares at $11.32 ($4,517)
From the SEC's structured data for this filing
Trades in this filing
Trigilio Jeffrey · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-20 | Sale : show line 1 in the form | −399 | $11.32 | $4,517 | 88,003 | D |
| Open-market sales · 399 sh · avg $11.32 · $4,517 | ||||||
Loading xslF345X04/doc4.xml…